HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 35 filers reported holding HEPION PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $149,026 | +224.5% | 191,754 | +25.3% | 0.00% | – |
| Q4 2022 | $45,918 | -61.1% | 153,029 | -33.7% | 0.00% | – |
| Q3 2022 | $118,000 | +3.5% | 230,690 | +16.8% | 0.00% | – |
| Q2 2022 | $114,000 | -68.4% | 197,569 | -29.5% | 0.00% | – |
| Q1 2022 | $361,000 | -40.0% | 280,099 | -46.9% | 0.00% | – |
| Q4 2021 | $602,000 | -47.7% | 527,714 | -29.9% | 0.00% | – |
| Q3 2021 | $1,152,000 | -33.3% | 753,152 | -13.7% | 0.00% | – |
| Q2 2021 | $1,728,000 | -25.5% | 872,566 | -30.8% | 0.00% | – |
| Q1 2021 | $2,320,000 | +90.2% | 1,260,661 | +126.3% | 0.00% | – |
| Q4 2020 | $1,220,000 | +2159.3% | 557,064 | +3083.2% | 0.00% | – |
| Q3 2020 | $54,000 | – | 17,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 57,309 | $178,000 | 0.03% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 15,552 | $48,000 | 0.00% |
| Squarepoint Ops LLC | 15,524 | $48,000 | 0.00% |
| ExodusPoint Capital Management, LP | 11,632 | $36,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 33,215 | $103,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 57 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 15,786 | $49,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 29,233 | $91,000 | 0.00% |
| MORGAN STANLEY | 54 | $0 | 0.00% |